Institutional investors purchased a net $9.8 million shares of NEO during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 56.12% of shares outstanding that institutional investors hold is actually below the Medical/Nursing Services industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DRIEHAUS CAPITAL MANAGEMENT LLC Bought 1.9 Million shares of Neogenomics Inc
ARTISAN PARTNERS LP Bought 1.9 Million shares of Neogenomics Inc
KOPP INVESTMENT ADVISORS LLC Bought 1.1 Million shares of Neogenomics Inc